Arrowhead Research | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
Agios Pharmaceuticals USD 51.7M 13.16M 2024-12
Alnylam Pharmaceuticals USD 295.34M 74.35M 2024-12
Arrowhead Research USD 30.2M 1.91M 2024-12
Incyte USD 326.71M 17.5M 2024-12
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
Ligand Pharmaceuticals USD 25.6M 1.13M 2024-12
Merck USD 2.85B 148M 2024-12
Moderna USD 351M 70M 2024-12
Novartis USD 3.5B 368M 2024-12
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
TG Therapeutics USD 38.96M 3M 2024-12
Ultragenyx Pharmaceutical USD 82.49M 2.14M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Xencor USD 14.92M 148K 2024-12



Arrowhead Research Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.